There is significant underutilization of antithrombotic and anticoagulant therapies for stroke prophylaxis in older patients with atrial fibrillation, even among those without contraindications.
No takes yet. Share an insight, caveat, or question.
Underutilization of stroke prophylaxis persists in older AF patients; leaves open optimal strategies to improve rates among those without contraindications.
Lawson et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: